Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA AI In Drug Repurposing Market, by Component
1.4.2 LAMEA AI In Drug Repurposing Market, by Technology
1.4.3 LAMEA AI In Drug Repurposing Market, by End Use
1.4.4 LAMEA AI In Drug Repurposing Market, by Application
1.4.5 LAMEA AI In Drug Repurposing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Market Trends – LAMEA AI In Drug Repurposing Market
Chapter 5. State of Competition - LAMEA AI in Drug Repurposing market
Chapter 6. Value Chain Analysis of AI In Drug Repurposing Market
Chapter 7. Product Life Cycle – AI In Drug Repurposing Market
Chapter 8. Market Consolidation – AI In Drug Repurposing Market
Chapter 9. Key Customer Criteria – AI In Drug Repurposing Market
Chapter 10. LAMEA AI In Drug Repurposing Market by Component
10.1 LAMEA Software & Platform Market by Country
10.2 LAMEA Services Market by Country
Chapter 11. LAMEA AI In Drug Repurposing Market by Technology
11.1 LAMEA Machine Learning/Deep Learning Market by Country
11.2 LAMEA Natural Language Processing (NLP) Market by Country
11.3 LAMEA Knowledge Graphs & Network-Based AI Market by Country
11.4 LAMEA Generative AI & Large Language Models (LLMs) Market by Country
11.5 LAMEA Computer Vision Market by Country
Chapter 12. LAMEA AI In Drug Repurposing Market by End Use
12.1 LAMEA Pharmaceutical & BioTechnology Companies Market by Country
12.2 LAMEA Contract Research Organizations (CROs) Market by Country
12.3 LAMEA Academic & Research Institutes Market by Country
12.4 LAMEA Other End Use Market by Country
Chapter 13. LAMEA AI In Drug Repurposing Market by Application
13.1 LAMEA Oncology Market by Country
13.2 LAMEA Neurology Market by Country
13.3 LAMEA Infectious Diseases Market by Country
13.4 LAMEA Rare & Orphan Diseases Market by Country
13.5 LAMEA Cardiology Market by Country
13.6 LAMEA Other Application Market by Country
Chapter 14. LAMEA AI In Drug Repurposing Market by Country
14.1 Brazil AI In Drug Repurposing Market
14.1.1 Brazil AI In Drug Repurposing Market by Component
14.1.2 Brazil AI In Drug Repurposing Market by Technology
14.1.3 Brazil AI In Drug Repurposing Market by End Use
14.1.4 Brazil AI In Drug Repurposing Market by Application
14.2 Argentina AI In Drug Repurposing Market
14.2.1 Argentina AI In Drug Repurposing Market by Component
14.2.2 Argentina AI In Drug Repurposing Market by Technology
14.2.3 Argentina AI In Drug Repurposing Market by End Use
14.2.4 Argentina AI In Drug Repurposing Market by Application
14.3 UAE AI In Drug Repurposing Market
14.3.1 UAE AI In Drug Repurposing Market by Component
14.3.2 UAE AI In Drug Repurposing Market by Technology
14.3.3 UAE AI In Drug Repurposing Market by End Use
14.3.4 UAE AI In Drug Repurposing Market by Application
14.4 Saudi Arabia AI In Drug Repurposing Market
14.4.1 Saudi Arabia AI In Drug Repurposing Market by Component
14.4.2 Saudi Arabia AI In Drug Repurposing Market by Technology
14.4.3 Saudi Arabia AI In Drug Repurposing Market by End Use
14.4.4 Saudi Arabia AI In Drug Repurposing Market by Application
14.5 South Africa AI In Drug Repurposing Market
14.5.1 South Africa AI In Drug Repurposing Market by Component
14.5.2 South Africa AI In Drug Repurposing Market by Technology
14.5.3 South Africa AI In Drug Repurposing Market by End Use
14.5.4 South Africa AI In Drug Repurposing Market by Application
14.6 Nigeria AI In Drug Repurposing Market
14.6.1 Nigeria AI In Drug Repurposing Market by Component
14.6.2 Nigeria AI In Drug Repurposing Market by Technology
14.6.3 Nigeria AI In Drug Repurposing Market by End Use
14.6.4 Nigeria AI In Drug Repurposing Market by Application
14.7 Rest of LAMEA AI In Drug Repurposing Market
14.7.1 Rest of LAMEA AI In Drug Repurposing Market by Component
14.7.2 Rest of LAMEA AI In Drug Repurposing Market by Technology
14.7.3 Rest of LAMEA AI In Drug Repurposing Market by End Use
14.7.4 Rest of LAMEA AI In Drug Repurposing Market by Application
Chapter 15. Company Profiles
15.1 Ginkgo Bioworks Holdings, Inc.
15.1.1 Company Overview
15.1.2 Financial Analysis
15.1.3 Segmental and Regional Analysis
15.1.4 Research & Development Expenses
15.1.5 Recent strategies and developments:
15.1.5.1 Partnerships, Collaborations, and Agreements:
15.1.6 SWOT Analysis
15.2 IBM Corporation
15.2.1 Company Overview
15.2.2 Financial Analysis
15.2.3 Regional & Segmental Analysis
15.2.4 Research & Development Expenses
15.2.5 Recent strategies and developments:
15.2.5.1 Partnerships, Collaborations, and Agreements:
15.2.6 SWOT Analysis
15.3 Atomwise, Inc.
15.3.1 Company Overview
15.4 Cyclica, Inc.
15.4.1 Company Overview
15.5 Genesis Healthcare Co.
15.5.1 Company Overview
15.6 Verge, Inc.
15.6.1 Company Overview
15.7 Novartis AG
15.7.1 Company Overview
15.7.2 Financial Analysis
15.7.3 Segmental and Regional Analysis
15.7.4 Research & Development Expenses
15.7.5 SWOT Analysis
15.8 Schrödinger, Inc
15.8.1 Company Overview
15.8.2 Financial Analysis
15.8.3 Segmental and Regional Analysis
15.8.4 Research & Development Expenses
15.9 Recursion Pharmaceuticals, Inc.
15.9.1 Company Overview
15.9.2 Financial Analysis
15.9.3 Research & Development Expenses
15.10. The Cradle Company
15.10.1 Company Overview
Unique Offerings 